Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniela Massi

Showing results (341-350 of 357) with videos related to

Pageof 36
Sort By:
Oncotarget|October 21, 2017
mTORC1/autophagy-regulated MerTK in mutant BRAFV600 melanoma with acquired resistance to BRAF inhibitionGongda Xue, Reto Kohler, Fengyuan Tang, et al.
Journal for Immunotherapy of Cancer|November 16, 2019
The density and spatial tissue distribution of CD8<sup>+</sup> and CD163<sup>+</sup> immune cells predict response and outcome in melanoma patients receiving MAPK inhibitorsDaniela Massi, Eliana Rulli, Mara Cossa, et al.
Human Pathology|November 26, 2010
The impact of histopathologic examination of graft-versus-host disease in the era of reduced-intensity conditioning regimen: a study from the Gruppo Italiano Trapianto di Midollo OsseoDaniela Massi, Cristina Fondi, Chiara Nozzoli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 30, 2020
Tumor CD155 Expression Is Associated with Resistance to Anti-PD1 Immunotherapy in Metastatic MelanomaAilin Lepletier, Jason Madore, Jake S O'Donnell, et al.
The American Journal of Surgical Pathology|March 25, 2024
BRAF Mutated and Morphologically Spitzoid Tumors, a Subgroup of Melanocytic Neoplasms Difficult to Distinguish From True Spitz NeoplasmsPedram Gerami, Alice Chen, Natasha Sharma, et al.
Histopathology|November 20, 2025
WHO classification of skin tumours: key updates in the fifth editionGabrielle Goldman-Lévy, Raymond Barnhill, Boris C Bastian, et al.
European Journal of Cancer (Oxford, England : 1990)|September 5, 2024
Efficacy of anti PD-1 therapy in children and adolescent melanoma patients (MELCAYA study)Mario Mandalà, Andrea Ferrari, Ines B Brecht, et al.
Human Pathology|March 14, 2026
The Impact of Next Generation Sequencing Studies on the Diagnosis of BAP1 Inactivated Melanocytic TumorsJonathan Braat, Nithya Sai Trichy, Lindsay Jeanne Holic, et al.
The American Journal of Surgical Pathology|November 10, 2021
Impact of Next-generation Sequencing on Interobserver Agreement and Diagnosis of Spitzoid NeoplasmsSarah Benton, Jeffrey Zhao, Bin Zhang, et al.
The American Journal of Surgical Pathology|April 9, 2024
The Impact of Next-generation Sequencing on Interobserver Agreement and Diagnostic Accuracy of Desmoplastic Melanocytic NeoplasmsAlice Chen, Natasha Sharma, Pragi Patel, et al.
Pageof 36

Showing results (341-350 of 357) with videos related to

Sort By:
Pageof 36
Oncotarget|October 21, 2017
mTORC1/autophagy-regulated MerTK in mutant BRAFV600 melanoma with acquired resistance to BRAF inhibitionGongda Xue, Reto Kohler, Fengyuan Tang, et al.
Journal for Immunotherapy of Cancer|November 16, 2019
The density and spatial tissue distribution of CD8<sup>+</sup> and CD163<sup>+</sup> immune cells predict response and outcome in melanoma patients receiving MAPK inhibitorsDaniela Massi, Eliana Rulli, Mara Cossa, et al.
Human Pathology|November 26, 2010
The impact of histopathologic examination of graft-versus-host disease in the era of reduced-intensity conditioning regimen: a study from the Gruppo Italiano Trapianto di Midollo OsseoDaniela Massi, Cristina Fondi, Chiara Nozzoli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 30, 2020
Tumor CD155 Expression Is Associated with Resistance to Anti-PD1 Immunotherapy in Metastatic MelanomaAilin Lepletier, Jason Madore, Jake S O'Donnell, et al.
The American Journal of Surgical Pathology|March 25, 2024
BRAF Mutated and Morphologically Spitzoid Tumors, a Subgroup of Melanocytic Neoplasms Difficult to Distinguish From True Spitz NeoplasmsPedram Gerami, Alice Chen, Natasha Sharma, et al.
Histopathology|November 20, 2025
WHO classification of skin tumours: key updates in the fifth editionGabrielle Goldman-Lévy, Raymond Barnhill, Boris C Bastian, et al.
European Journal of Cancer (Oxford, England : 1990)|September 5, 2024
Efficacy of anti PD-1 therapy in children and adolescent melanoma patients (MELCAYA study)Mario Mandalà, Andrea Ferrari, Ines B Brecht, et al.
Human Pathology|March 14, 2026
The Impact of Next Generation Sequencing Studies on the Diagnosis of BAP1 Inactivated Melanocytic TumorsJonathan Braat, Nithya Sai Trichy, Lindsay Jeanne Holic, et al.
The American Journal of Surgical Pathology|November 10, 2021
Impact of Next-generation Sequencing on Interobserver Agreement and Diagnosis of Spitzoid NeoplasmsSarah Benton, Jeffrey Zhao, Bin Zhang, et al.
The American Journal of Surgical Pathology|April 9, 2024
The Impact of Next-generation Sequencing on Interobserver Agreement and Diagnostic Accuracy of Desmoplastic Melanocytic NeoplasmsAlice Chen, Natasha Sharma, Pragi Patel, et al.
Pageof 36